Unlock instant, AI-driven research and patent intelligence for your innovation.

Synthesis of antiviral compound

A technology for compounds, reaction mixtures, applied in antiviral agents, drug combinations, organic chemistry, etc., which can solve problems such as limited practicality

Active Publication Date: 2015-04-15
GILEAD SCI INC
View PDF2 Cites 26 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although drugs targeting the liver are widely used and have shown effectiveness, toxicity and other side effects limit their usefulness

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Synthesis of antiviral compound
  • Synthesis of antiviral compound
  • Synthesis of antiviral compound

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0173] I. Synthesis of Starting Materials

[0174]

[0175] A. Cyclopropanation, Preparation 2

[0176] To a room temperature solution of DCM (1.5 L) and n-heptane (0.32 L) was added diethylzinc (800 mL, 1.0 M in n-heptane). The reaction mixture was cooled to 0 °C and a solution of compound 1 (45.0 g) in DCM (250 mL) was added over 10 min. When the addition was complete, the reaction mixture was cooled to -5 °C and chloroiodomethane (176 g) was added via syringe pump over 3.5 h. The reaction mixture was stirred at -5 °C for another 16 h and quenched by the slow addition (1 h) of 1 N aqueous HCl (1.4 L). After warming to 20 °C, the phases were separated and the aqueous layer was back extracted with DCM (0.5 L). The combined organic layers were washed with 10% aqueous NaCl (1.2 L), the phases were separated, and the organic layer was concentrated in vacuo to provide a crude oil, which was purified by silica gel flash chromatography (50% ethyl acetate / n-heptane). The desir...

Embodiment approach

[0238]

[0239] I. Cyclopropanation

[0240]

[0241] Cyclopropane to 12

[0242] Therefore, compound 1 (40 . 0g, 1.0eq), BnN(Me) 3 Cl (2.3 g, 0.07 eq), bromoform (45 mL, 3.0 eq) and DCM (280 mL) were added to the flask. The resulting solution was stirred at 33 °C and 50% sodium hydroxide solution (120 mL) was added within 1.5-2 h (internal temperature did not exceed 38 °C). The solution was aged at 33°C until the reaction was considered complete as determined by HPLC analysis. The contents of the flask were cooled to 22 °C, water (100 mL) was added, and the layer was allowed to stand for 2 h. The bottom aqueous layer was removed, and the upper organic layer was washed with 4M HCl (120 mL). The bottom organic layer was retained, and the upper aqueous layer was removed. The organic layer was then washed with water (80 mL). The lower organic layer was slurried with silica gel (12 g) for 1 h. The silica gel was filtered off and the waste cake was washed once with DC...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present disclosure provides processes for the preparation of a compound of formula I: which is useful as an antiviral agent. The disclosure also provides compounds that are synthetic intermediates to compounds of formula I.

Description

[0001] Cross References to Related Applications [0002] This application claims priority to U.S. Provisional Application Serial No. 61 / 655,935, filed June 5, 2012, and U.S. Provisional Application Serial No. 13 / 800,202, filed March 13, 2013, both of which are incorporated by reference in their entirety into this article. Background technique [0003] The present invention relates generally to the field of organic synthesis methods for the preparation of antiviral compounds and intermediates for their synthesis. [0004] Hepatitis C is considered a chronic viral disease of the liver characterized by liver disease. Although drugs that target the liver are widely used and have shown effectiveness, toxicity and other side effects limit their usefulness. Inhibitors of hepatitis C virus (HCV) are useful for limiting the establishment and progression of HCV infection and for use in diagnostic tests for HCV. Contents of the invention [0005] In one embodiment, the present inven...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D403/04C07D403/14
CPCC07D403/14C07D403/04C07B2200/13A61P1/16A61P31/12A61P31/14Y02P20/55A61K31/4178A61K31/4184
Inventor 罗伯特·威廉·斯科特贾斯汀·菲利普·维塔莱肯尼斯·斯坦利·马修斯马丁·杰拉德·特里斯克亚历山德拉·弗姆拉杰瑞德·韦恩·埃文斯
Owner GILEAD SCI INC